BIOINFORMATICS ANALYSIS OF GENE EXPRESSION PATTERNS IN BREAST CANCER
Abstract
Breast cancer is one of the leading causes of cancer-related mortality among women worldwide and is characterized by substantial molecular heterogeneity. The present study aimed to analyse gene expression patterns associated with breast cancer using bioinformatics approaches and to identify potential molecular biomarkers related to different breast cancer subtypes. A publicly available microarray dataset, Breast_GSE45827, consisting of 151 samples and more than 54,000 gene expression features, was utilized for computational analysis. The dataset included normal breast tissue samples and multiple breast cancer subtypes, including basal, HER2-positive, luminal A, luminal B, and cell line samples. Data preprocessing and normalization procedures were performed to improve dataset quality and comparability among samples. Exploratory data analysis, differential gene expression analysis, Principal Component Analysis (PCA), and hierarchical clustering were subsequently conducted to investigate molecular expression patterns and subtype-specific variations. Several significantly dysregulated genes associated with tumour progression, cell proliferation, immune response, and metastasis were identified. PCA and clustering analyses demonstrated distinct molecular signatures among breast cancer subtypes, particularly within basal and HER2-positive groups. The analysis also identified potential biomarker genes that may contribute to breast cancer diagnosis, prognosis, and personalized therapeutic strategies. The findings highlighted the effectiveness of bioinformatics methods in analysing large-scale genomic datasets and identifying clinically relevant molecular targets in breast cancer. The present study contributes to the understanding of breast cancer molecular mechanisms and supports the potential application of computational biology approaches in biomarker
discovery and cancer genomics research.
Downloads
References
Chen, W. Q., Yang, S. J., Xu, W. X., Deng, F., Wang, D. D., & Tang, J. H. (2021). Bioinformatics analysis revealing
prognostic significance of TIMP2 gene in breast cancer. Medicine, 100(42), e27489.
Fiscon, G., Funari, A., & Paci, P. (2023). Circular RNA mediated gene regulation in human breast cancer: A
bioinformatics analysis. Plos one, 18(7), e0289051.
Golestan, A., Tahmasebi, A., Maghsoodi, N., Faraji, S. N., Irajie, C., & Ramezani, A. (2024). Unveiling promising
breast cancer biomarkers: an integrative approach combining bioinformatics analysis and experimental
verification. BMC cancer, 24(1), 155.
Grisci, B. (2020). Breast cancer gene expression - CuMiDa [Data set]. Kaggle.
https://www.kaggle.com/datasets/brunogrisci/breast-cancer-gene-expression-cumida
Hozhabri, H., Moghaddam, M. M., Moghaddam, M. M., & Mohammadian, A. (2022). A comprehensive
bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast
cancer. Scientific Reports, 12(1), 10374.
Li, C., Cui, J., Zou, L., Zhu, L., & Wei, W. (2020). Bioinformatics analysis of the expression of HOXC13 and its role
in the prognosis of breast cancer. Oncology letters, 19(1), 899-907.
Li, X., Gou, J., Li, H., & Yang, X. (2020). Bioinformatic analysis of the expression and prognostic value of chromobox
family proteins in human breast cancer. Scientific reports, 10(1), 17739.
Liang, Z., Wang, X., Dong, K., Li, X., Qin, C., & Zhou, H. (2021). Expression pattern and prognostic value of
EPHA/EFNA in breast cancer by bioinformatics analysis: revealing its importance in chemotherapy. BioMed Research
International, 2021(1), 5575704.
Lu, Y., Yang, G., Xiao, Y., Zhang, T., Su, F., Chang, R., ... & Bai, Y. (2020). Upregulated cyclins may be novel genes
for triple-negative breast cancer based on bioinformatic analysis. Breast Cancer, 27(5), 903-911.
Ma, J., Chen, C., Liu, S., Ji, J., Wu, D., Huang, P., ... & Ren, L. (2022). Identification of a five genes prognosis
signature for triple-negative breast cancer using multi-omics methods and bioinformatics analysis. Cancer Gene
Therapy, 29(11), 1578-1589.
Mehraj, U., Alshehri, B., Khan, A. A., Bhat, A. A., Bagga, P., Wani, N. A., & Mir, M. A. (2022). Expression pattern
and prognostic significance of chemokines in breast cancer: an integrated bioinformatics analysis. Clinical Breast
Cancer, 22(6), 567-578.
Mehraj, U., Sofi, S., Alshehri, B., & Mir, M. A. (2022). Expression pattern and prognostic significance of CDKs in
breast cancer: an integrated bioinformatic study. Cancer Biomarkers, 34(3), 505-519.
Mo, L., Liu, J., Yang, Z., Gong, X., Meng, F., Zou, R., ... & Fang, F. (2020). DNAJB4 identified as a potential breast
cancer marker: evidence from bioinformatics analysis and basic experiments. Gland Surgery, 9(6), 1955.
Ramos, S., Ferreira, S., Fernandes, A. S., & Saraiva, N. (2022). Lysyl oxidases expression and breast cancer
progression: a bioinformatic analysis. Frontiers in pharmacology, 13, 883998.
Ren, H., Hu, D., Mao, Y., & Su, X. (2020). Identification of genes with prognostic value in the breast cancer
microenvironment using bioinformatics analysis. Medical Science Monitor: International Medical Journal of
Experimental and Clinical Research, 26, e920212-1.
Rezaeijo, S. M., Rezaei, M., Poursheikhani, A., Mohammadkhani, S., Goharifar, N., Shayankia, G., ... & Taghizadeh,
E. (2023). Integrative bioinformatics analysis of miRNA and mRNA expression profiles identified some potential
biomarkers for breast cancer. Egyptian Journal of Medical Human Genetics, 24(1), 62.
Tian, Y., Liu, X., Hu, J., Zhang, H., Wang, B., Li, Y., ... & Yu, Y. (2021). Integrated bioinformatic analysis of the
expression and prognosis of caveolae-related genes in human breast cancer. Frontiers in Oncology, 11, 703501.
Wang, Y., Li, Y., Liu, B., & Song, A. (2021). Identifying breast cancer subtypes associated modules and biomarkers
by integrated bioinformatics analysis. Bioscience reports, 41(1), BSR20203200.
Wu, G., Xiao, G., Yan, Y., Guo, C., Hu, N., & Shen, S. (2022). Bioinformatics analysis of the clinical significance of
HLA class II in breast cancer. Medicine, 101(40), e31071.
Yadav, D. K., Sharma, A., Dube, P., Shaikh, S., Vaghasia, H., & Rawal, R. M. (2022). Identification of crucial hub
genes and potential molecular mechanisms in breast cancer by integrated bioinformatics analysis and experimental
validation. Computers in Biology and Medicine, 149, 106036.
Yan, S., & Yue, S. (2023). Identification of early diagnostic biomarkers for breast cancer through bioinformatics
analysis. Medicine, 102(37), e35273.
Zeng, C., Lin, M., Jin, Y., & Zhang, J. (2022). Identification of key genes associated with brain metastasis from breast
cancer: a bioinformatics analysis. Medical Science Monitor: International Medical Journal of Experimental and
Clinical Research, 28, e935071-1.
Zhang, M., Chen, H., Wang, M., Bai, F., & Wu, K. (2020). Bioinformatics analysis of prognostic significance of
COL10A1 in breast cancer. Bioscience reports, 40(2), BSR20193286.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 International Journal For Research In Biology & Pharmacy

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
In consideration of the journal, Green Publication taking action in reviewing and editing our manuscript, the authors undersigned hereby transfer, assign, or otherwise convey all copyright ownership to the Editorial Office of the Green Publication in the event that such work is published in the journal. Such conveyance covers any product that may derive from the published journal, whether print or electronic. Green Publication shall have the right to register copyright to the Article in its name as claimant, whether separately
or as part of the journal issue or other medium in which the Article is included.
By signing this Agreement, the author(s), and in the case of a Work Made For Hire, the employer, jointly and severally represent and warrant that the Article is original with the author(s) and does not infringe any copyright or violate any other right of any third parties, and that the Article has not been published elsewhere, and is not being considered for publication elsewhere in any form, except as provided herein. Each author’s signature should appear below. The signing author(s) (and, in



